MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
17.70
+0.05 (0.28%)
Apr 14, 2026, 4:00 PM EDT - Market closed
MediWound Market Cap
MediWound has a market cap or net worth of $227.48 million as of April 14, 2026. Its market cap has increased by 23.96% in one year.
Market Cap
227.48M
Enterprise Value
183.12M
1-Year Change
23.96%
Ranking
Category
Stock Price
$17.70
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $262.70M to $227.48M, a decrease of -13.40%. That is a compound annual growth rate of -1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 226.84M | -4.16% |
| Dec 31, 2025 | 236.68M | 23.23% |
| Dec 31, 2024 | 192.06M | 104.85% |
| Dec 29, 2023 | 93.76M | 19.44% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 245.30M |
| Camp4 Therapeutics | 240.91M |
| ALX Oncology Holdings | 234.26M |
| Voyager Therapeutics | 233.03M |
| Context Therapeutics | 226.94M |
| Jyong Biotech | 226.86M |
| Nuvectis Pharma | 224.12M |
| MacroGenics | 223.10M |